Inventor
SULSKY RICHARD B
US42 patents
⚠️ This page may combine multiple inventors who share the name “SULSKY RICHARD B”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
27 patentsUS6548529B1Apr 15, 2003
Heterocyclic containing biphenyl aP2 inhibitors and method
BRISTOL MYERS SQUIBB CO273 citations99
US6395767B2May 28, 2002
Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method
BRISTOL MYERS SQUIBB CO398 citations99
US5962440AOct 5, 1999
Cyclic phosphonate ester inhibitors of microsomal triglyceride transfer protein and method
BRISTOL MYERS SQUIBB CO173 citations99
US5739135AApr 14, 1998
Inhibitors of microsomal triglyceride transfer protein and method
BRISTOL MYERS SQUIBB CO297 citations99
US5712279AJan 27, 1998
Inhibitors of microsomal triglyceride transfer protein and method
BRISTOL MYERS SQUIBB CO319 citations99
US6573287B2Jun 3, 2003
2,1-oxazoline and 1,2-pyrazoline-based inhibitors of dipeptidyl peptidase IV and method
BRISTOL MYERS SQUIBB CO112 citations98
US6472414B1Oct 29, 2002
Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method
BRISTOL MYERS SQUIBB CO42 citations92
US6066650AMay 23, 2000
Inhibitors of microsomal triglyceride transfer protein and method
BRISTOL MYERS SQUIBB CO26 citations92
US5883099AMar 16, 1999
Inhibitors of microsomal triglyceride transfer protein and method
BRISTOL MYERS SQUIBB CO29 citations92
US7417028B2Aug 26, 2008
Human glucagon-like-peptide-1 modulators and their use in treatment of diabetes and related conditions
BRISTOL MYERS SQUIBB CO20 citations91
US7884113B2Feb 8, 2011
Tetrahydroquinoline derivatives as cannabinoid receptor modulators
BRISTOL MYERS SQUIBB CO8 citations83
US7276608B2Oct 2, 2007
Tetrahydroquinoline derivatives as cannabinoid receptor modulators
BRISTOL MYERS SQUIBB CO6 citations74
US5470845ANov 28, 1995
Methods of using α-phosphonosulfonate squalene synthetase inhibitors including the treatment of atherosclerosis and hypercholesterolemia
BRISTOL MYERS SQUIBB CO14 citations74
US7166596B2Jan 23, 2007
Heterocyclic aromatic compounds useful as growth hormone secretagogues
BRISTOL MYERS SQUIBB CO9 citations73
US6984645B2Jan 10, 2006
Dual inhibitors of adipocyte fatty acid binding protein and keratinocyte fatty acid binding protein
BRISTOL MYERS SQUIBB CO8 citations73
US5567841AOct 22, 1996
α-phosphonosulfonate squalene synthetase inhibitors and method
BRISTOL MYERS SQUIBB CO7 citations63
US7910601B2Mar 22, 2011
Heterocyclic aromatic compounds useful as growth hormone secretagogues
BRISTOL MYERS SQUIBB CO2 citations62
US6034098AMar 7, 2000
Inhibitors of microsomal triglyceride transfer protein and method
BRISTOL MYERS SQUIBB CO3 citations62
US7960349B2Jun 14, 2011
N-terminally modified GLP-1 receptor modulators
BRISTOL MYERS SQUIBB CO2 citations61
US7534763B2May 19, 2009
Sustained release GLP-1 receptor modulators
BRISTOL MYERS SQUIBB CO5 citations59
US8030306B2Oct 4, 2011
Azabicyclic heterocycles as cannabinoid receptor modulators
BRISTOL MYERS SQUIBB CO1 citations52
US7977353B2Jul 12, 2011
Heterocyclic aromatic compounds useful as growth hormone secretagogues
BRISTOL MYERS SQUIBB CO0 citations52
US7799801B2Sep 21, 2010
Heterocyclic aromatic compounds useful as growth hormone secretagogues
BRISTOL MYERS SQUIBB CO0 citations52
US7592354B2Sep 22, 2009
Heterocyclic aromatic compounds useful as growth hormone secretagogues
BRISTOL MYERS SQUIBB CO0 citations52
US7589102B2Sep 15, 2009
Heterocyclic aromatic compounds useful as growth hormone secretagogues
BRISTOL MYERS SQUIBB CO0 citations52
US7572808B2Aug 11, 2009
Triazolopyridine cannabinoid receptor 1 antagonists
BRISTOL MYERS SQUIBB CO1 citations52
US7220859B2May 22, 2007
Bicyclic heterocycles as cannabinoid receptor modulators
BRISTOL MYERS SQUIBB CO1 citations52
ORTHO PHARMA CORP
4 patentsUS4820828AApr 11, 1989
Cinnamohydroxamic acids
ORTHO PHARMA CORP78 citations96
US5066658ANov 19, 1991
Substituted hydroxyureas
ORTHO PHARMA CORP35 citations92
US5464865ANov 7, 1995
4-aryl- and 4-arylthio-5-hydroxy-2(5H)-furanones as inhibitors of phospholipase A2
ORTHO PHARMA CORP7 citations73
US4904667AFeb 27, 1990
1H-1,2,4-thiadiazolo(3,4-b)quinazolin-5-one-2,2-dioxides, and a method for increasing the cardiac output of a mammal with them
ORTHO PHARMA CORP9 citations73
(unassigned)
3 patentsUS5760246AJun 2, 1998
Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method
304 citations99
US5712396AJan 27, 1998
α-phosphonosulfonate squalene synthetase inhibitors
196 citations99
US5712261AJan 27, 1998
Method for preventing or treating hypertriglyceridemia
3 citations63